-+ 0.00%
-+ 0.00%
-+ 0.00%

Adicon Holdings (SEHK:9860) Stock Hinges On Margin Repair And Rich Valuation

Simply Wall St·08/26/2026 11:18:39
Listen to the news

Adicon Holdings stock closed at HK$3.58 on Wednesday, roughly flat over the past week after a choppy few months. The market reaction looks muted, yet the earnings story is sharper. The key headline is profit quality. H1 2026 basic earnings per share came in at CN¥0.04 and the trailing twelve month P/E sits at 95.1x, far above the Hong Kong healthcare industry. That gap highlights a longer term consideration: how much patience do you have for a turnaround that now hinges on sustaining cleaner margins after a large one off loss?

Love the potential for cleaner margins at Adicon Holdings but concerned about paying a 95.1x P/E multiple for an earnings turnaround story? Check out the 293 resilient stocks with low risk scores for companies that combine more measured valuations with lower risk scores.

H1 2026 Earnings Summary

  • Revenue (H1 2026 vs H1 2025): CN¥1,284.764m vs. CN¥1,270.559m (broadly stable period on period)
  • Net Income (Excl. Extra Items, H1 2026 vs H1 2025): CN¥32.006m vs. CN¥27.273m (modest improvement in underlying profit)
  • Basic EPS (H1 2026 vs H1 2025): CN¥0.04 vs. CN¥0.038404 (small uplift in earnings per share)
  • Trailing Twelve Month Net Income (Excl. Extra Items, to H1 2026 vs. to H1 2025 H1): CN¥23.176m vs. a loss of CN¥27.295m (swing back to profitability on an underlying basis, helped by the absence of the prior large one off loss of CN¥43.9m)

Tired of wading through dense earnings tables and raw figures for Adicon Holdings? See the full financial picture with a clear visual view of its valuation story and recent profitability trends in the company report for Adicon Holdings.

SEHK:9860 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
SEHK:9860 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

Adicon Holdings: Earnings Momentum And Margin Repair

The bullish story around Adicon Holdings as a defensive healthcare provider finds some support in the latest numbers. Revenue of CN¥1,284.764m in H1 2026 is broadly in line with H1 2025, which fits the idea of steady demand from hospitals and health check clients. More importantly for an earnings recovery angle, underlying net income improved to CN¥32.006m and basic EPS ticked up to CN¥0.04. The move from an underlying loss over the prior twelve months to a CN¥23.176m profit points to cleaner margins after the earlier one off hit.

Regulation And Execution Risks Still In View

The cautious narrative around Adicon Holdings is not entirely eased by these results. Profitability is still modest relative to more than CN¥1.28b of revenue, which leaves limited room for error if pricing or regulatory pressure on testing volumes appears. The earlier large one off loss of CN¥43.9m may be behind the company, yet it highlights operational and regulatory sensitivity. Recent share price moves, with a 90 day decline of 15.566% alongside a 30 day bounce, suggest investors are still weighing these execution and policy risks carefully.

After a CN¥43.9m one off hit, are Adicon Holdings margins truly cleaner or still fragile? Review our risk analysis for Adicon Holdings which shows 1 important warning sign

Stay Ahead Of Your Next Move

If Adicon Holdings has your attention after the recent margin repair story and high 95.1x P/E, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and watch how the earnings story develops. Once you are invested, use the Portfolio Command Center to cut through noise and focus on the most important updates across all your holdings. For a longer term view, tap into collective insight through the Community and see how other investors are thinking about opportunities and risks. By spotting potential catalysts and red flags early, you give yourself a better chance of staying ahead of the market.

Seeking Alternatives Beyond Adicon Holdings?

Fresh ideas move first when momentum builds and prices start flying. Spot potential breakouts while they are still under the radar for now. Do the work early and act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.